thestar.com.my
May 20, 2008
WASHINGTON (Reuters) - The drug is finasteride, formerly sold by Merck and Co as Proscar to treat enlargement of the prostate and now available generically. When the initial results of the study were announced, the researchers cautioned that men in the study who developed prostate cancer while...
[read full story]